Randomized Polypill Crossover Trial in People Aged 50 and Over

@inproceedings{Wald2012RandomizedPC,
  title={Randomized Polypill Crossover Trial in People Aged 50 and Over},
  author={David S Wald and Joan K Morris and Nicholas J Wald},
  booktitle={PloS one},
  year={2012}
}
BACKGROUND A Polypill is proposed for the primary prevention of cardiovascular disease in people judged to be at risk on account of their age alone. Its efficacy in reducing cholesterol and blood pressure is uncertain. METHODS We conducted a randomized double-blind placebo-controlled crossover trial of a Polypill among individuals aged 50+ without a history of cardiovascular disease and compared the reductions with those predicted from published estimates of the effects of the individual… CONTINUE READING